# Karuna Pharmaceuticals Inc — Form D

Karuna Pharmaceuticals Inc of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-06-09. The offering totals $600K, of which $600K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2011-06-09
- Form: D
- Accession: 0001522897-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $600K
- Amount sold: $600K
- Investors: 7
- Date of first sale: 2011-05-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-161041

## Issuer

- Name: Karuna Pharmaceuticals Inc
- CIK: 0001522897
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 500 BOYLSTON STREET, BOSTON, MA, 02116
- Phone: 617-482-2333

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Eric Marc Elenko | Director | Boston, MA |
| Edmund Harrigan | Director | Boston, MA |
| Stephen Marc Muniz | Director | Boston, MA |
| Steven Marc Paul | Director | Boston, MA |
| Daphne Marc Zohar | Director | Boston, MA |
| Edmund Harrigan | Executive Officer | Boston, MA |

## More

- [CIK 1522897 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1522897&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001522897-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.